Intravitreal Melphalan for Refractory or Recurrent Vitreous Seeding From Retinoblastoma

Abstract

Intravitreal melphalan for recurrent vitreous seeds from retinoblastoma appears to provide vitreous seed control in some patients. A high dose (50 μg) of melphalan is toxic and should be avoided.